| AHR | Aryl hydrocarbon receptor |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazole |
| ANOVA | Analysis of variance |
| AOI | Area of interest |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| ELISA | Enzyme-linked immunosorbent assay |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase |
| GYKI52466 | a 2,3-benzodiazepine, which is non-competitive AMPA receptor antagonist |
| Iba1 | Ionized calcium binding adaptor molecule 1 |
| iGluR | Ionotropic glutamate receptor |
| IL-6 | Interleukin-6 |
| KYNA | Kynurenic acid |
| KP | Kynurenine pathway |
| LPS | Lipopolysaccharide, endotoxin |
| mTOR | Mammalian target of rapamycin |
| mTORC1 | Multi-protein complex containing mTOR protein |
| NF-κB | Nuclear factor kappa-light-chain-enhances of activated B cells; protein complex regulating cellular responses |
| NMDA | N-methyl-D-aspartic acid |
| PILO | Pilocarpine |
| RT-PCR | Reverse transcription polymerase chain reaction |
| QUIN | Quinolinic acid |
| SEM | Standard error of the mean |
| SZR104 | N-(2-(dimethylamino)ethyl)-3-(morpholinomethyl)-4-hydroxyquinoline-2-carboxamide |
| TLR4 | Toll-like receptor4 |
| TNFα | Tumor necrosis factor-alpha |
| TRPA1,4 | Transient receptor potential ankyrin 1,4 receptors |